← Back to LFMD filing summaryOriginal filing text · Part I
Item 3 — Quantitative and Qualitative Disclosures About Market Risk
Lifemd, Inc. · 10-Q · Q2 FY2026 · Period ended Jun 30, 2026
View complete filing on SEC EDGAR ↗This is the extracted source text from the SEC filing. Formatting may differ from the original document.
Interest
Rate Risk
Our
exposure to interest rate fluctuations relate primarily to our cash accounts. We had cash totaling $25.1 million and $36.8 million, as
of June 30, 2026 and December 31, 2025, respectively, which was held for working capital, capital expenditure, and general corporate
purposes. As of June 30, 2026, our cash balances are comprised of interest-bearing cash accounts. We do not hold or issue financial instruments
for trading or speculative purposes. Given the nature of these accounts, we do not believe there is material exposure to interest rate
risk.
Item